Release details

2018-06-12 18:44 CEST
  • Print
  • Share Share
en fr

PHARMAGEST INTERACTIVE : ANNUAL ORDINARY AND EXTRAORDINARY GENERAL MEETING - Notice

Villers-lès-Nancy, 12 June 2018 - 6:30 p.m. (CET)
PRESS RELEASE

Annual Ordinary and Extraordinary General Meeting

Notice

The shareholders of PHARMAGEST INTERACTIVE are invited to attend the Annual Ordinary and Extraordinary General Meeting that will be held on Thursday, June 28, 2018 at 5.00 pm, at headquarters located in VILLERS-LES-NANCY (54600), 5 allée de Saint Cloud.

The agenda and the draft resolutions were published in the BALO (Bulletin des Annonces Légales et Obligatoires) of May 21, 2018 (www.journal-officiel.gouv.fr).

The present notice of meeting was published on the June 11, 2018 in the BALO, in the Official Journal "Tablettes Lorraines", and on the company's website (www.pharmagest.com / Finance).

Shareholders will be able to obtain the documents with regard to this Shareholders' Meeting on request from the company's registered office in VILLERS-LES-NANCY (54600).

About PHARMAGEST Group:

Pharmagest Group is the French pharmacy information technology leader, with a market share of more than 42% and more than 1,000 employees. The Group's strategy is based on a core business of improving healthcare through information technology innovation and developing two priority areas: 1/ Services and technologies for healthcare professionals, with a focus on assisting pharmacies in patient medication compliance; and 2/ technologies for improving the efficacy of healthcare systems.

To roll out this strategy, Pharmagest Group has developed specialised businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for pharmaceutical laboratories, connected health devices and apps, and a sales financing marketplace.

These businesses are divided into four divisions: Pharmacy - Europe Solutions; Health and Social Care Facilities Solutions; e-Health Solutions and Fintech.

Listed on Euronext Paris(TM) - Compartment B
Indices: CAC® SMALL and CAC® All-Tradable par inclusion
Eligible for the Long-Only Deferred Settlement Service (SRD)
ISIN: FR 0012882389 - Reuters: PHA.PA - Bloomberg: - PMGI FP

For all the latest news go to www.pharmagest.com

CONTACTS

Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@lacooperativewelcoop.com

Financial Communications and Media Relations:
FIN'EXTENSO - Isabelle APRILE
Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr

HUG#2198915